Werewolf Therapeutics (HOWL) Income Statement (2020 - 2026)
Income Statement report data from Mar 31, 2020 to Mar 31, 2026 for Werewolf Therapeutics (HOWL).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | -3.31M | 970K (-2.02%) | 990K (-26.67%) | 1.35M (+14.41%) | 1.18M (+100.00%) | 590K (+490.00%) | 100K (+150.00%) | 40K | -20.00K | 50K (0.00%) | 50K (+150.00%) | 20K | -10.00K (0.00%) | -10.00K | 20K (-71.43%) | 70K |
Operating Expenses | |||||||||||||||||||||||||
Research And Development | 8.18M (+18.04%) | 6.93M (-40.41%) | 12M (-11.49%) | 13M (+0.15%) | 13M (-16.59%) | 16M (+25.54%) | 13M (-17.94%) | 15M (+18.28%) | 13M (+33.78%) | 9.65M (-10.98%) | 11M (+13.15%) | 9.58M (-18.19%) | 12M (-26.17%) | 16M (+21.35%) | 13M (-5.90%) | 14M (+26.85%) | 11M (-18.28%) | 13M (+36.87%) | 9.79M (+34.66%) | 7.27M (+50.83%) | 4.82M (-8.88%) | 5.29M (+9.98%) | 4.81M (+27.25%) | 3.78M (+36.96%) | 2.76M |
Selling General And Administrative | 5.09M (+104.42%) | 2.49M (-39.12%) | 4.09M (-7.05%) | 4.40M (-9.65%) | 4.87M (+5.41%) | 4.62M (+0.43%) | 4.60M (-4.76%) | 4.83M (-3.40%) | 5.00M (+3.95%) | 4.81M (+11.60%) | 4.31M (-5.69%) | 4.57M (-8.23%) | 4.98M (+8.26%) | 4.60M (+3.60%) | 4.44M (-15.11%) | 5.23M (+18.33%) | 4.42M (-1.34%) | 4.48M (+11.72%) | 4.01M (+8.67%) | 3.69M (+39.77%) | 2.64M (+25.12%) | 2.11M (+70.16%) | 1.24M (-3.88%) | 1.29M (+14.16%) | 1.13M |
Operating Expenses | 13M (+40.87%) | 9.42M (-40.11%) | 16M (-10.32%) | 18M (-2.50%) | 18M (-11.60%) | 20M (+18.87%) | 17M (-14.83%) | 20M (+12.29%) | 18M (+23.79%) | 14M (-4.55%) | 15M (+7.07%) | 14M (-15.22%) | 17M (-18.43%) | 20M (+16.85%) | 18M (-8.42%) | 19M (+24.40%) | 15M (-14.04%) | 18M (+29.57%) | 14M (+25.91%) | 11M (+47.11%) | 7.45M (+0.81%) | 7.39M (+22.15%) | 6.05M (+19.33%) | 5.07M (+30.33%) | 3.89M |
Depreciation And Amortization | 400K (-66.94%) | 1.21M | - | - | 430K (-68.15%) | 1.35M | - | - | 460K (-65.67%) | 1.34M | - | - | 430K (-57.43%) | 1.01M | - | - | 100K (-44.44%) | 180K | - | - | 40K (-69.23%) | 130K | - | - | 20K |
Operating Income | |||||||||||||||||||||||||
Operating Income | -13.27M (+40.87%) | -9.42M (-40.11%) | -15.73M (-10.32%) | -17.54M (-2.50%) | -17.99M (-11.60%) | -20.35M (+18.87%) | -17.12M (-9.70%) | -18.96M (+10.49%) | -17.16M (+32.41%) | -12.96M (+40.11%) | -9.25M (+52.39%) | -6.07M (-50.33%) | -12.22M (-7.28%) | -13.18M (+5.10%) | -12.54M (-16.23%) | -14.97M (-2.60%) | -15.37M (-14.04%) | -17.88M (+29.66%) | -13.79M (+25.82%) | -10.96M (+47.11%) | -7.45M (+0.81%) | -7.39M (+22.15%) | -6.05M (+19.33%) | -5.07M (+30.33%) | -3.89M |
Ebit | -13.27M (+40.87%) | -9.42M (-40.11%) | -15.73M (-10.32%) | -17.54M (-2.50%) | -17.99M (-11.60%) | -20.35M (+18.87%) | -17.12M (-9.70%) | -18.96M (+10.49%) | -17.16M (+32.41%) | -12.96M (+40.11%) | -9.25M (+52.39%) | -6.07M (-50.33%) | -12.22M (-7.28%) | -13.18M (+5.10%) | -12.54M (-16.23%) | -14.97M (-2.60%) | -15.37M (-14.04%) | -17.88M (+29.66%) | -13.79M (+25.82%) | -10.96M (+47.11%) | -7.45M (+0.81%) | -7.39M (+22.15%) | -6.05M (+19.33%) | -5.07M (+30.33%) | -3.89M |
EBITDA | -12.87M (+31.73%) | -9.77M (-35.00%) | -15.03M (-9.89%) | -16.68M (-5.07%) | -17.57M (-24.27%) | -23.20M (+50.36%) | -15.43M (-6.20%) | -16.45M (-1.50%) | -16.70M (+7.67%) | -15.51M (+113.05%) | -7.28M (+75.85%) | -4.14M (-64.92%) | -11.80M (-10.27%) | -13.15M (+10.13%) | -11.94M (-18.16%) | -14.59M (-4.45%) | -15.27M (-14.12%) | -17.78M (+29.22%) | -13.76M (+26.01%) | -10.92M (+47.37%) | -7.41M (-49.14%) | -14.57M (+140.03%) | -6.07M | 2.26M | -3.87M |
Other Income / Expenses | |||||||||||||||||||||||||
Interest Income | 430K (-23.21%) | 560K (-20.00%) | 700K (-17.65%) | 850K (-15.00%) | 1.00M (-23.66%) | 1.31M (-18.13%) | 1.60M (-10.61%) | 1.79M (-9.14%) | 1.97M (-0.51%) | 1.98M (+0.51%) | 1.97M (+1.03%) | 1.95M (+28.29%) | 1.52M (-20.42%) | 1.91M | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | 1.37M (0.00%) | 1.37M (+2.24%) | 1.34M (+3.08%) | 1.30M (+3.17%) | 1.26M (+384.62%) | 260K (-79.03%) | 1.24M (+55.00%) | 800K (-20.00%) | 1.00M (-0.99%) | 1.01M (+1.00%) | 1.00M (+4.17%) | 960K (+464.71%) | 170K | - | - | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 430K (-23.21%) | 560K (-20.00%) | 700K (-17.65%) | 850K (-15.00%) | 1.00M (-56.71%) | 2.31M (+44.38%) | 1.60M (-10.61%) | 1.79M (+84.54%) | 970K | -990.00K | 1.97M (+1.03%) | 1.95M (+44.44%) | 1.35M (-29.32%) | 1.91M | - | - | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 670K (-66.83%) | 2.02M | - | 10K (-94.12%) | 170K (-89.51%) | 1.62M (+1520.00%) | 100K (-93.79%) | 1.61M | - | -1.14M | - | -20.00K (-98.20%) | -1.11M | 340K | - | 280K | -20.00K | 100K | -20.00K (0.00%) | -20.00K (0.00%) | -20.00K | 7.36M | -10.00K | - | - |
Net Income | |||||||||||||||||||||||||
Net Income From Continuing Operations | -13.53M (+61.46%) | -8.38M (-48.81%) | -16.37M (-8.95%) | -17.98M (-0.61%) | -18.09M (-11.32%) | -20.40M (+22.38%) | -16.67M (-3.36%) | -17.25M (+6.55%) | -16.19M (+34.92%) | -12.00M (+44.93%) | -8.28M (+62.35%) | -5.10M (-57.43%) | -11.98M (+0.42%) | -11.93M (-0.08%) | -11.94M (-18.16%) | -14.59M (-4.89%) | -15.34M (-14.16%) | -17.87M (+29.87%) | -13.76M (+26.01%) | -10.92M (+46.97%) | -7.43M (+0.41%) | -7.40M (+21.91%) | -6.07M | 2.26M | -3.83M |
Net Income | -13.53M (+61.46%) | -8.38M (-48.81%) | -16.37M (-8.95%) | -17.98M (-0.61%) | -18.09M (-11.32%) | -20.40M (+22.38%) | -16.67M (-3.36%) | -17.25M (+6.55%) | -16.19M (+34.92%) | -12.00M (+44.93%) | -8.28M (+62.35%) | -5.10M (-57.43%) | -11.98M (+0.42%) | -11.93M (-0.08%) | -11.94M (-18.16%) | -14.59M (-4.89%) | -15.34M (-14.16%) | -17.87M (+29.87%) | -13.76M (+26.01%) | -10.92M (+46.97%) | -7.43M (+0.41%) | -7.40M (+21.91%) | -6.07M | 2.26M | -3.83M |